[109th Scientific Meeting of the Japanese Society of Internal medicine: symposium: 1. Recent treatments and progress in malignant tumors--chemotherapy and molecular targeting agents. Antibody therapy; 4) Progress and diversification in treatment for hematological malignancies].

Hideo Harigae

doi:10.2169/naika.101.2526

[109th Scientific Meeting of the Japanese Society of Internal medicine: symposium: 1. Recent treatments and progress in malignant tumors--chemotherapy and molecular targeting agents. Antibody therapy; 4) Progress and diversification in treatment for hematological malignancies].

医学系研究科・医科学専攻

研究成果: Article › 査読

本文言語	English
ページ（範囲）	2526-2531
ページ数	6
ジャーナル	Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
巻	101
号	9
DOI	https://doi.org/10.2169/naika.101.2526
出版ステータス	Published - 2012 9月 10

ASJC Scopus subject areas

医学（全般）

文献へのアクセス

10.2169/naika.101.2526

他のファイルとリンク

引用スタイル

Harigae, H. (2012). [109th Scientific Meeting of the Japanese Society of Internal medicine: symposium: 1. Recent treatments and progress in malignant tumors--chemotherapy and molecular targeting agents. Antibody therapy; 4) Progress and diversification in treatment for hematological malignancies]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 101(9), 2526-2531. https://doi.org/10.2169/naika.101.2526

[109th Scientific Meeting of the Japanese Society of Internal medicine : symposium: 1. Recent treatments and progress in malignant tumors--chemotherapy and molecular targeting agents. Antibody therapy; 4) Progress and diversification in treatment for hematological malignancies]. / Harigae, Hideo.

In: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, Vol. 101, No. 9, 10.09.2012, p. 2526-2531.

研究成果: Article › 査読

Harigae, H 2012, '[109th Scientific Meeting of the Japanese Society of Internal medicine: symposium: 1. Recent treatments and progress in malignant tumors--chemotherapy and molecular targeting agents. Antibody therapy; 4) Progress and diversification in treatment for hematological malignancies].', Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, vol. 101, no. 9, pp. 2526-2531. https://doi.org/10.2169/naika.101.2526

Harigae H. [109th Scientific Meeting of the Japanese Society of Internal medicine: symposium: 1. Recent treatments and progress in malignant tumors--chemotherapy and molecular targeting agents. Antibody therapy; 4) Progress and diversification in treatment for hematological malignancies]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. 2012 9月 10;101(9):2526-2531. doi: 10.2169/naika.101.2526

Harigae, Hideo. / [109th Scientific Meeting of the Japanese Society of Internal medicine : symposium: 1. Recent treatments and progress in malignant tumors--chemotherapy and molecular targeting agents. Antibody therapy; 4) Progress and diversification in treatment for hematological malignancies]. In: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. 2012 ; Vol. 101, No. 9. pp. 2526-2531.

@article{0032839e18004af59c546eebcaf0ff37,

title = "[109th Scientific Meeting of the Japanese Society of Internal medicine: symposium: 1. Recent treatments and progress in malignant tumors--chemotherapy and molecular targeting agents. Antibody therapy; 4) Progress and diversification in treatment for hematological malignancies].",

author = "Hideo Harigae",

year = "2012",

month = sep,

day = "10",

doi = "10.2169/naika.101.2526",

language = "English",

volume = "101",

pages = "2526--2531",

journal = "Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine",

issn = "0021-5384",

publisher = "Japanese Society of Internal Medicine",

number = "9",

}

TY - JOUR

T1 - [109th Scientific Meeting of the Japanese Society of Internal medicine

T2 - symposium: 1. Recent treatments and progress in malignant tumors--chemotherapy and molecular targeting agents. Antibody therapy; 4) Progress and diversification in treatment for hematological malignancies].

AU - Harigae, Hideo

PY - 2012/9/10

Y1 - 2012/9/10

UR - http://www.scopus.com/inward/record.url?scp=84875001075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875001075&partnerID=8YFLogxK

U2 - 10.2169/naika.101.2526

DO - 10.2169/naika.101.2526

M3 - Article

C2 - 23205429

AN - SCOPUS:84875001075

SN - 0021-5384

VL - 101

SP - 2526

EP - 2531

JO - Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

JF - Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

IS - 9

ER -